Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Atopibact Creme is a topical dermatological product developed by Metis Healthcare, an Italian B2B consumer healthcare company. It is part of a product line that includes Atopibact Water and utilizes the proprietary MH-BactoProtech technology platform. The product is designed for skin care applications, likely targeting atopic dermatitis or related conditions by leveraging microbiome-focused formulations. Unlike traditional pharmaceutical candidates, Atopibact Creme is developed as a consumer healthcare or over-the-counter (OTC) formulation, focusing on stages such as design, scale-up, and registration rather than conventional clinical trial phases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Atopibact Creme.